Clinical Trials Directory

Trials / Completed

CompletedNCT04877366

Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia

A Randomized, Double-blind, Placebo- and Active-Controlled, Single-Center, Three-time-period, Crossover Study to Evaluate the Effects of Sprinkled Format REDUCOSE on Post-Prandial Glycemic Response in Asian Patients with Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

This is a mechanistic, single-center, double-blind, placebo- and active-controlled, three-time-period, crossover study to evaluate the effect of sprinkled format REDUCOSE compared to placebo (double-blind; confirmative) and active control (open-label; acarbose - explorative) on post prandial glycemia in Asian patients with type 2 diabetes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary Supplement: Sprinkled Format REDUCOSE.2 G powder sprinkle containing 250 mg REDUCOSE (mulberry leaf extract - 250 mg - 5% DNJ) + fiber, vitamin D, and chromium picolinate
OTHERReference controlA placebo matching to the test product will be used as control
OTHERActive comparatorAcarbose 100 mg tablet (provided in open-label format)

Timeline

Start date
2021-07-21
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2021-05-07
Last updated
2024-10-15

Locations

2 sites across 2 countries: United States, Singapore

Source: ClinicalTrials.gov record NCT04877366. Inclusion in this directory is not an endorsement.

Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia (NCT04877366) · Clinical Trials Directory